Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203879531> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3203879531 abstract "Abstract Background: Rare diseases have been increasingly recognized as medical and healthy burden worldwide, a growing demand for the development of orphan drugs emerges subsequently. Therefore, it is of great interest for both the regulatory agency and pharmaceutical companies to keep tract on the clinical orphan drug development in China. Objective and Method: This study aims to reveal the current situation and trend of the clinical development of orphan drugs in China, based on the data collected from the Platform for Drug Clinical Trials and Information Registration（http://www.chinadrugtrials.org.cn）of China Food and Drug Administration, dating from 2013 to March 8, 2021. Results: A total of 246 clinical trials for orphan drugs are extracted from the Platform, covering 22 rare diseases and 90 drugs. Among the 22 rare diseases, 3 (14 %) have more than 50 trials each , 17 (77%) had less than10 trials, and 10 (46%) only with one trial. Among 90 orphan drugs, 60 (67%) were chemical drugs, and 30 (33 %) were biological products. In addition, international multi-center trials accounts for nearly 10% of the total trials. The number of the trials with the Data Monitoring Security Committee (DMC) is 25 (10%) and the number of the trials with the trial injury insurance for subjects is 154 (63%). Furthermore, more than half of the total trials are carried in east (333, 30%) and north China (298, 27%), whereas a small portion are in the northwest (62, 6%) and northeast china (45, 4%). Conclusions: The clinical development of orphan drugs for rare diseases in China has made some progress in the passing decades. However, a couple of critical issues still need to be addressed, such as unmet needs for some rare diseases, low coverage of insurance and DMC, and uneven distribution of medical resources for clinical researches. Recommendations are put forward accordingly, which can provide improvement goals for policy makers and stakeholders involved in drug development for rare diseases." @default.
- W3203879531 created "2021-10-11" @default.
- W3203879531 creator A5007870017 @default.
- W3203879531 creator A5013099614 @default.
- W3203879531 creator A5063333893 @default.
- W3203879531 creator A5064649413 @default.
- W3203879531 creator A5068825836 @default.
- W3203879531 date "2021-09-23" @default.
- W3203879531 modified "2023-10-16" @default.
- W3203879531 title "Current Status and Trend of Clinical Development of Orphan Drugs in China" @default.
- W3203879531 doi "https://doi.org/10.21203/rs.3.rs-915751/v1" @default.
- W3203879531 hasPublicationYear "2021" @default.
- W3203879531 type Work @default.
- W3203879531 sameAs 3203879531 @default.
- W3203879531 citedByCount "0" @default.
- W3203879531 crossrefType "posted-content" @default.
- W3203879531 hasAuthorship W3203879531A5007870017 @default.
- W3203879531 hasAuthorship W3203879531A5013099614 @default.
- W3203879531 hasAuthorship W3203879531A5063333893 @default.
- W3203879531 hasAuthorship W3203879531A5064649413 @default.
- W3203879531 hasAuthorship W3203879531A5068825836 @default.
- W3203879531 hasBestOaLocation W32038795311 @default.
- W3203879531 hasConcept C126322002 @default.
- W3203879531 hasConcept C166957645 @default.
- W3203879531 hasConcept C17744445 @default.
- W3203879531 hasConcept C191935318 @default.
- W3203879531 hasConcept C205649164 @default.
- W3203879531 hasConcept C2780035454 @default.
- W3203879531 hasConcept C3018890749 @default.
- W3203879531 hasConcept C3019398576 @default.
- W3203879531 hasConcept C3116431 @default.
- W3203879531 hasConcept C535046627 @default.
- W3203879531 hasConcept C60644358 @default.
- W3203879531 hasConcept C64903051 @default.
- W3203879531 hasConcept C71924100 @default.
- W3203879531 hasConcept C75480439 @default.
- W3203879531 hasConcept C86803240 @default.
- W3203879531 hasConcept C98274493 @default.
- W3203879531 hasConceptScore W3203879531C126322002 @default.
- W3203879531 hasConceptScore W3203879531C166957645 @default.
- W3203879531 hasConceptScore W3203879531C17744445 @default.
- W3203879531 hasConceptScore W3203879531C191935318 @default.
- W3203879531 hasConceptScore W3203879531C205649164 @default.
- W3203879531 hasConceptScore W3203879531C2780035454 @default.
- W3203879531 hasConceptScore W3203879531C3018890749 @default.
- W3203879531 hasConceptScore W3203879531C3019398576 @default.
- W3203879531 hasConceptScore W3203879531C3116431 @default.
- W3203879531 hasConceptScore W3203879531C535046627 @default.
- W3203879531 hasConceptScore W3203879531C60644358 @default.
- W3203879531 hasConceptScore W3203879531C64903051 @default.
- W3203879531 hasConceptScore W3203879531C71924100 @default.
- W3203879531 hasConceptScore W3203879531C75480439 @default.
- W3203879531 hasConceptScore W3203879531C86803240 @default.
- W3203879531 hasConceptScore W3203879531C98274493 @default.
- W3203879531 hasLocation W32038795311 @default.
- W3203879531 hasOpenAccess W3203879531 @default.
- W3203879531 hasPrimaryLocation W32038795311 @default.
- W3203879531 hasRelatedWork W1537699525 @default.
- W3203879531 hasRelatedWork W2082673550 @default.
- W3203879531 hasRelatedWork W2097742807 @default.
- W3203879531 hasRelatedWork W2113832503 @default.
- W3203879531 hasRelatedWork W2341166473 @default.
- W3203879531 hasRelatedWork W2387362168 @default.
- W3203879531 hasRelatedWork W2388075619 @default.
- W3203879531 hasRelatedWork W2604239722 @default.
- W3203879531 hasRelatedWork W2912386223 @default.
- W3203879531 hasRelatedWork W3203879531 @default.
- W3203879531 isParatext "false" @default.
- W3203879531 isRetracted "false" @default.
- W3203879531 magId "3203879531" @default.
- W3203879531 workType "article" @default.